Elham Baghbani

1.6k total citations · 1 hit paper
55 papers, 1.2k citations indexed

About

Elham Baghbani is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Elham Baghbani has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 29 papers in Cancer Research and 17 papers in Immunology. Recurrent topics in Elham Baghbani's work include MicroRNA in disease regulation (26 papers), Circular RNAs in diseases (15 papers) and RNA Interference and Gene Delivery (10 papers). Elham Baghbani is often cited by papers focused on MicroRNA in disease regulation (26 papers), Circular RNAs in diseases (15 papers) and RNA Interference and Gene Delivery (10 papers). Elham Baghbani collaborates with scholars based in Iran, Italy and Denmark. Elham Baghbani's co-authors include Behzad Baradaran, Saeed Noorolyai, Sanam Sadreddini, Neda Shajari, Behzad Mansoori, Vahid Khaze, Ali Mohammadi, Dariush Shanehbandi, Ahad Mokhtarzadeh and Amir Baghbanzadeh and has published in prestigious journals such as Gene, Life Sciences and Journal of Cellular Physiology.

In The Last Decade

Elham Baghbani

54 papers receiving 1.2k citations

Hit Papers

The relation between PI3K/AKT signalling pathway and cancer 2019 2026 2021 2023 2019 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The relation between PI3K/AKT signalling pathway and cancer
    2019 463 citations Saeed Noorolyai, Elham Baghbani et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elham Baghbani Iran 19 756 487 275 190 131 55 1.2k
Călin Ionescu Romania 14 814 1.1× 447 0.9× 265 1.0× 114 0.6× 126 1.0× 20 1.3k
Hui Xing China 22 768 1.0× 387 0.8× 343 1.2× 122 0.6× 100 0.8× 54 1.2k
Rui Ling China 18 638 0.8× 395 0.8× 236 0.9× 100 0.5× 129 1.0× 63 1.1k
Shokooh Salimimoghadam Iran 22 863 1.1× 545 1.1× 258 0.9× 105 0.6× 193 1.5× 49 1.4k
Xupeng Bai China 15 874 1.2× 426 0.9× 386 1.4× 127 0.7× 180 1.4× 25 1.4k
Haiyan Hu China 22 917 1.2× 635 1.3× 221 0.8× 183 1.0× 139 1.1× 86 1.4k
Feng‐Hou Gao China 23 886 1.2× 253 0.5× 346 1.3× 191 1.0× 117 0.9× 50 1.4k
Ita Novita Sari South Korea 12 908 1.2× 346 0.7× 516 1.9× 128 0.7× 115 0.9× 19 1.4k
Hyunho Yoon South Korea 16 569 0.8× 277 0.6× 365 1.3× 123 0.6× 111 0.8× 30 1.1k
Xian Lin China 23 1.2k 1.6× 637 1.3× 476 1.7× 166 0.9× 181 1.4× 63 1.7k

Countries citing papers authored by Elham Baghbani

Since Specialization
Citations

This map shows the geographic impact of Elham Baghbani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Baghbani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Baghbani more than expected).

Fields of papers citing papers by Elham Baghbani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elham Baghbani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Baghbani. The network helps show where Elham Baghbani may publish in the future.

Co-authorship network of co-authors of Elham Baghbani

This figure shows the co-authorship network connecting the top 25 collaborators of Elham Baghbani. A scholar is included among the top collaborators of Elham Baghbani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elham Baghbani. Elham Baghbani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Shekari, Najibeh, Dariush Shanehbandi, Elham Baghbani, et al.. (2024). VSIG-3/IGSF11 silencing in A2058 melanoma cells simultaneously suppresses melanoma progression and induces anti-tumoral cytokine profile in human T cells: In silico and in vitro study. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(4). 3861–3880. 1 indexed citations
4.
Masoumi, Javad, Farid Ghorbaninezhad, Leili Aghebati‐Maleki, et al.. (2024). Boosting immunotherapy efficacy: Empowering the Potency of Dendritic cells loaded with breast cancer lysates through CTLA-4 suppression. Heliyon. 10(18). e37699–e37699. 2 indexed citations
5.
Noorolyai, Saeed, et al.. (2024). Effects of CD44 siRNA on inhibition, survival, and apoptosis of breast cancer cell lines (MDA-MB-231 and 4T1). Molecular Biology Reports. 51(1). 646–646. 1 indexed citations
6.
Kazemi, Tohid, Mohammad Reza Sadeghi, Javad Ahmadian Heris, et al.. (2023). Glyburide-treated human monocyte-derived dendritic cells loaded with insulin represent tolerogenic features with anti-inflammatory responses and modulate autologous T cell responses in vitro. International Immunopharmacology. 126. 111230–111230. 7 indexed citations
7.
Masoumi, Javad, Farid Ghorbaninezhad, Hossein Saeedi, et al.. (2023). siRNA-Mediated B7H7 Knockdown in Gastric Cancer Lysate-Loaded Dendritic Cells Amplifies Expansion and Cytokine Secretion of Autologous T Cells. Biomedicines. 11(12). 3212–3212. 7 indexed citations
8.
9.
Gharibi, Tohid, Arezoo Hosseini, Faroogh Marofi, et al.. (2023). STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balance. International Immunopharmacology. 119. 110160–110160. 7 indexed citations
10.
Khordadmehr, Monireh, et al.. (2022). mir-451a-5p Modulates Breast Cancer Cell Apoptosis, Migration, and Chemosensitivity to Carboplatin through the PTEN Pathway. Pharmaceutical Sciences. 29(3). 328–337. 1 indexed citations
11.
Khordadmehr, Monireh, et al.. (2022). The Effect of miR-4800 Restoration on Proliferation and Migration of Human Breast Cancer Cells In Vitro. Advanced Pharmaceutical Bulletin. 13(2). 378–384. 1 indexed citations
12.
Doustvandi, Mohammad Amin, Mahdi Abdoli Shadbad, H. Tajalli, et al.. (2022). Photodynamic therapy with zinc phthalocyanine enhances the anti-cancer effect of tamoxifen in breast cancer cell line: Promising combination treatment against triple-negative breast cancer?. Photodiagnosis and Photodynamic Therapy. 41. 103212–103212. 9 indexed citations
13.
Mansoori, Behzad, Nicola Silvestris, Ali Mohammadi, et al.. (2021). miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient Prognosis. Genes. 12(2). 267–267. 37 indexed citations
14.
Baghbani, Elham, Saeed Noorolyai, Dariush Shanehbandi, et al.. (2021). Regulation of immune responses through CD39 and CD73 in cancer: Novel checkpoints. Life Sciences. 282. 119826–119826. 35 indexed citations
15.
Mansoori, Behzad, Ali Mohammadi, Dariush Shanehbandi, et al.. (2020). MicroRNA-143 inhibits proliferation and migration of prostate cancer cells. Archives of Physiology and Biochemistry. 128(5). 1323–1329. 8 indexed citations
16.
Hejazi, Maryam, Elham Baghbani, Mohammad Amini, et al.. (2019). MicroRNA‐193a and taxol combination: A new strategy for treatment of colorectal cancer. Journal of Cellular Biochemistry. 121(2). 1388–1399. 41 indexed citations
17.
Noorolyai, Saeed, Elham Baghbani, Leili Aghebati‐Maleki, et al.. (2019). Restoration of miR-193a-5p and miR-146 a-5p Expression Induces G1 Arrest in Colorectal Cancer through Targeting of MDM2/p53. Advanced Pharmaceutical Bulletin. 10(1). 130–134. 22 indexed citations
18.
Baradaran, Behzad, Abbas Azadmehr, Sima Mansoori Derakhshan, et al.. (2016). Extracts of Scrophularia frigida Boiss display potent antitumor effects in human breast cancer cells by inducing apoptosis and inhibition of expression of the human epidermal growth factor receptor 2.. PubMed. 62(9). 83–89. 3 indexed citations
19.
Mansoori, Behzad, Ali Mohammadi, Solmaz Shirjang, Elham Baghbani, & Behzad Baradaran. (2016). Micro RNA 34a and Let-7a Expression in Human Breast Cancers is Associated with Apoptotic Expression Genes. Asian Pacific Journal of Cancer Prevention. 17(4). 1887–1890. 35 indexed citations
20.
Baghbani, Elham, Behzad Baradaran, Fatemeh Pak, et al.. (2016). Suppression of protein tyrosine phosphatase PTPN22 gene induces apoptosis in T-cell leukemia cell line (Jurkat) through the AKT and ERK pathways. Biomedicine & Pharmacotherapy. 86. 41–47. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Călin Ionescu Breakdown of academic impact, for papers by Hui Xing Breakdown of academic impact, for papers by Rui Ling Breakdown of academic impact, for papers by Shokooh Salimimoghadam Breakdown of academic impact, for papers by Xupeng Bai Breakdown of academic impact, for papers by Haiyan Hu Breakdown of academic impact, for papers by Feng‐Hou Gao Breakdown of academic impact, for papers by Ita Novita Sari Breakdown of academic impact, for papers by Hyunho Yoon Breakdown of academic impact, for papers by Xian Lin
Rankless by CCL
2026